Can pirfenidone be a treatment modality in oral sub mucous fibrosis?

Journal Title: INTERNATIONAL JOURNAL OF CURRENT RESEARCH - Year 2018, Vol 10, Issue 4

Abstract

Oral submucous fibrosis (OSMF) is a potentially malignant collagen metabolic disorder affecting the oral cavity due to the imbalance in collagen production and breakdown mediated by transforming growth factor beta (TGF-β). Numerous modalities ranging from behavioural therapy, physiotherapy, steroids, enzymes, nutritional supplements, antioxidants, interferons, turmeric, ayurveda to various drugs have been tried with weak evidence requiring better documentation of the studies performed with standardized criteria. One drug perfinidone (5-methyl-1-phenyl-2-(1H) pyridine) a novel antifibrotic agent used extensively in lung, cardiac and liver fibrosis has still not been tried in OSMF. This drug mainly exerts it action blocking the action of TGF-β. A positive outcome with prolonged research and numerous clinical trials, evaluating the systemic and topical uses of pirfenidone in OSMF with can give a ray of hope to these patients, helping them achieve a better quality of life. This paper aims at proposing this drug in the treatment of OSMF which can be beneficial in managing this progressively debilitating disease, significantly improving quality of life.

Authors and Affiliations

Dr. Shesha Prasad, R. , Dr. Anuradha Pai, Dr. Anisha Yaji

Keywords

Related Articles

Effect of core muscle strengthening and behavioral therapy in the management of chronic non specific low back pain in nursing population

Background and Introduction: Core muscle strengthening and behavioural therapy are the two main treatment strategies employed in the management of chronic non specific low back pain in nursing population. But there is ve...

Critical analysis of biomarkers in periodontal practice : a brief review

Background: Early diagnosis and treatment of progressive periodontitis is important because of the irreversible nature of periodontal disease. . In the field of periodontology, traditional clinical criteria are often ins...

“Blood”: Prevalence of blood borne infectious diseases in a large population observed over blood donors

Aim: To determine the prevalence of Rh positivity, distribution of blood groups, Blood Borne Infectious Diseases (BBID), age and weight related to blood donors, test validation and post donation counseling among the Sout...

A comparative evaluation of microbial adherence on heat activated polymethyl methacrylate denture base resin after being polished by three commercially available polishing agents

Aim: To evaluate the amount of adherence Streptococcus mutans on polished denture surface after being polished by three different polishing agents. Materials and Methods: After polymerization and finishing the samples of...

Mesh repair versus Non-mesh anatomical repair of primary Midline Ventral Hernias

Introduction: While mesh hernioplasty is increasingly getting popular, anatomical repair of ventral hernia is still commonly done by surgeons. In this study we have compared the effectiveness of mesh hernioplasty versus...

Download PDF file
  • EP ID EP403530
  • DOI -
  • Views 142
  • Downloads 0

How To Cite

Dr. Shesha Prasad, R. , Dr. Anuradha Pai, Dr. Anisha Yaji (2018). Can pirfenidone be a treatment modality in oral sub mucous fibrosis?. INTERNATIONAL JOURNAL OF CURRENT RESEARCH, 10(4), 67789-67793. https://www.europub.co.uk/articles/-A-403530